ECONOMYNEXT – An intravenous (IV) fluids manufacturing plant is to be set up in an industrial park in central Sri Lanka with an investment of at least 12 million dollars to serve the local and export markets, the investment promotion agency said.
The Board of Investment said in a statement that it had signed an agreement for the project with Kelun Life Sciences (Private) Limited for the plant in the Kandy Industrial Park.
“The project will employ 110 workers. The investment value of the project is US$ 12-75 million of which US$ 9.5 will be foreign direct investment.”
Kelun Life Sciences plans to manufacture injectables to supply to the Health Ministry, helping reduce shortages in the country, resulting in freshly manufactured stocks and also contributing towards import substitution, the statement said.